Clinical trial
The Efficacy of a Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Subacute Ischemic Stroke Patients - a Pivotal Study (the "EMAGINE 2.0" Study)
NCT06386874 is registered in ClinicalTrials.gov with BrainQ Technologies Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of a Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Subacute Ischemic Stroke Patients - a Pivotal Study (the "EMAGINE 2.0" Study)
- Lead sponsor
- BrainQ Technologies Ltd.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 20, 2024
- Completion date
- October 31, 2026
- Enrollment
- 122 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.